相关实验视频
Updated: Jun 14, 2025

06:01
Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
683
克鲁茨菲尔特 - 雅各布病:临床病例
Khrystyna Yuskiv1, Anzhelika Payenok2, Radu Protsiuk3
1SECOND MEDICAL UNION, 5TH HOSPITAL, LVIV, UKRAINE.
概括
这项研究详细介绍了两个罕见的克鲁茨菲尔特-雅各布病 (CJD) 病例,这是一个快速进展的神经退行性疾病. 两名患者都出现了严重的神经症状,突出了CJD变体的多样化临床表现.
科学领域:
- 神经学 神经学
- 神经退行性疾病 神经退行性疾病
- 子疾病是子疾病.
背景情况:
- 克鲁茨菲尔特 - 雅各布病 (CJD) 是一种罕见的致命性普里昂疾病,其特征是神经退行迅速.
- 海登海因和布朗内尔-奥本海默变异呈现出明显的初始神经学缺陷.
- 早期识别对于患者管理至关重要,尽管治愈仍然难以捉摸.
研究的目的:
- 介绍克鲁茨菲尔特-雅各布病的两个不同的临床病例.
- 为了说明海登海因和布朗内尔-奥本海默CJD变异的各种表现.
- 要强调与CJD相关的快速进展和严重的神经损伤.
主要方法:
- 病例报告分析了两名患有快速渐进的神经衰退的患者.
- 临床评估包括神经学检查和格拉斯哥昏迷表评分.
- 审查患者病史和亲属报告的症状.
主要成果:
- 案例1:一名68岁的妇女患有昏昏欲睡,严重的语言障碍,痴呆症,视力障碍,步态问题和失忆症 (海登海因变种).
- 案例2:一名67岁的男性头痛,头,步行和协调问题,四肢虚弱,失方向和记忆障碍 (布朗纳尔-奥本海默变异).
- 这两种病例都在短时间内表现出极快的症状进展.
结论:
- 克鲁茨菲尔特-雅各布病可以表现为多样化和快速进展的神经症状.
- 海登海因和布朗内尔-奥本海默CjD变异呈现出特有的,但严重的临床特征.
- 及时识别CJD对于支持性护理和家庭咨询至关重要,尽管缺乏治愈治疗方法.
相关概念视频
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499

